XBiotech Inc.
General ticker "XBIT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $81.4M (TTM average)
XBiotech Inc. does not follow the US Stock Market performance with the rate: -15.5%.
Estimated limits based on current volatility of 1.7%: low 2.36$, high 2.45$
Factors to consider:
- Total employees count: 92 as of 2024
- Top business risk factors: Regulatory and compliance, Product development risks, Supply chain disruptions, Labor/talent shortage/retention, Market acceptance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.77$, 3.96$]
- 2026-12-31 to 2027-12-31 estimated range: [2.06$, 4.42$]
Financial Metrics affecting the XBIT estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.39 > -0.60
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 93.52 > 64.29
Short-term XBIT quotes
Long-term XBIT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $37.51MM | $42.47MM | $55.69MM |
| Operating Income | $-37.51MM | $-42.47MM | $-55.69MM |
| Non-Operating Income | $13.20MM | $3.91MM | $10.38MM |
| Interest Expense | $0.00MM | $0.81MM | $0.09MM |
| R&D Expense | $32.85MM | $37.76MM | $47.39MM |
| Income(Loss) | $-24.31MM | $-38.56MM | $-45.30MM |
| Taxes | $0.24MM | $-0.03MM | $0.23MM |
| Net Income(Loss)* | $-24.56MM | $-38.53MM | $-45.54MM |
| Stockholders Equity | $218.85MM | $182.27MM | $140.35MM |
| Assets | $226.62MM | $199.09MM | $150.08MM |
| Operating Cash Flow | $-18.73MM | $-30.96MM | $-39.92MM |
| Capital expenditure | $0.36MM | $1.30MM | $0.29MM |
| Investing Cash Flow | $61.50MM | $-1.30MM | $-0.29MM |
| Financing Cash Flow | $-0.01MM | $10.45MM | $-10.25MM |
| Earnings Per Share** | $-0.81 | $-1.26 | $-1.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.